Dr Gavin Fullstone presented "Development of Tools for Systems Modelling of Cell Death Signalling" at the Agent-based Modelling User Meeting, Sheffield, UK in October 2017 and "Modelling Apoptotic Signalling Processes using an Agent-based Approach" at the 4th Annual Meeting of the FOR2036 BCL-2 Consortium, Obergurgl, Austria in January 2018.
GLIOTRAIN participated in the 22nd Annual Scientific Meeting of the Society for Neuro-Oncology (SNO) held in San Francisco, California in November 2017. Professor Byrne, GLIOTRAIN Coordinator, represented the GLIOTRAIN consortium at the event, meeting with Ms Kathy Oliver of the International Brain Tumour Alliance (IBTA) to discuss GLIOTRAIN’s strategy to address bench to bedside research from the patient’s perspective.
Dr Ahmed Idbaih presented at the European Society of Medical Oncology Asia 2017 Congress (Singapore, November 2017) in the session focussed on CNS tumours: Molecular alterations in clinical perspective: From discovery to everyday application in patient management.
Prof Simone Niclou presented an invited lecture entitled "Tumour-host interactions in Glioblastoma" in the Tumor Niche and Microenvironment workshop at the Journées Cancéropôle Grand Sud-Ouestheld in November 2017, Poitiers.
Dr Martine Lamfers gave a talk at the Dutch Working Group Neuro-Oncology in Utrecht (Netherlands) entitled "Drug screening of clinically available anti-cancer agents for the personalized treatment of glioblastoma patients" (September 2017).
A successful kick-off meeting for GLIOTRAIN was held on 25th September 2017 at the Royal College of Surgeons in Ireland. All beneficiary organisations were represented. Programme management, ESR training, network-wide training were discussed as well as scientific details underpinning individual research projects.